General Information of Drug Formulation (ID: F10767)

Formulation Name
Isoniazid 300 mg tablet
Company
Blenheim Phamacal; H. J. Harkins Company; Rebel Distributors
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Isoniazid DM5JVS3 Latent tuberculosis infection Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Beta-D-lactose E00099 6134 Diluent; Dry powder inhaler carrier; Lyophilization aid
Calcium stearate E00244 15324 lubricant
Stearic acid E00079 5281 Emulsifying agent; Solubilizing agent; Viscosity-controlling agent; lubricant